Pelthos Therapeutics (NYSE American: PTHS) announced that its 2026 Annual Meeting of Stockholders will be held virtually on Tuesday, September 29, 2026 at 9:00 a.m. Eastern Time. Stockholders of record at the close of business on August 4, 2026 may vote at the meeting.
Pelthos expects to file its Notice of Annual Meeting and proxy statement in early August 2026. Because the 2026 meeting date is more than 30 days from the 2025 meeting anniversary, stockholder proposals under Rule 14a-8 must be received by August 3, 2026 for inclusion in the proxy materials.
Loading...
Loading translation...
Positive
None.
Negative
None.
News Market Reaction – PTHS
+6.44%4.5x vol
9 alerts
+6.44%Session close to close
-5.5%Trough in 1 hr 41 min
$92.00MMarket Cap
4.5xRel. Volume
In the Jul 27 session, PTHS gained 6.44%, reflecting a notable positive market reaction.
Argus tracked a trough of -5.5% from its starting point during tracking.
Our momentum scanner triggered 9 alerts that day, indicating moderate trading interest and price volatility.
Trading volume was very high at 4.5x the daily average, suggesting strong buying interest.
The stock moved +6.4% in the session following this news. Pelthos previously recorded a 6.46% 24-hou...
Analysis
The stock moved +6.4% in the session following this news. Pelthos previously recorded a 6.46% 24-hour gain after news_id 1057374, providing a positive historical comparator for this scheduling notice. The active S-3 shelf permits offerings of up to $200,000,000, representing a sourced financing risk.
Key Figures
Annual Meeting Date:September 29, 2026 at 9:00 a.m. Eastern TimeRecord Date:August 4, 2026Meeting Date Change:More than 30 days+1 more
4 metrics
Annual Meeting DateSeptember 29, 2026 at 9:00 a.m. Eastern Time2026 Annual Meeting of Stockholders
Record DateAugust 4, 2026Stockholder voting eligibility
Meeting Date ChangeMore than 30 daysChange from the anniversary of the 2025 Annual Meeting
CEO scheduled one-on-one investor meetings at Piper Sandler biopharma symposium.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Pattern Detected
Recent news reactions were mixed, with positive earnings news aligning with a gain while index inclusion and conference news diverged from their price reactions.
Key Terms
rule 14a-8, proxy statement, stockholders of record
3 terms
rule 14a-8regulatory
"Stockholder proposals pursuant to Rule 14a-8 of the Securities Exchange Act"
Rule 14a-8 is a U.S. Securities and Exchange Commission regulation that lets eligible shareholders put proposals on a public company’s proxy ballot for an annual meeting, provided they meet basic ownership and filing requirements. It matters to investors because it creates a formal way to raise governance or strategic issues and force a company-wide vote—like getting an item onto the agenda of a neighborhood association meeting once you’ve lived there long enough—so shareholders can push for change or influence management decisions.
proxy statementregulatory
"The Company anticipates filing the Notice of Annual Meeting and proxy statement"
A proxy statement is a document companies send to shareholders ahead of a meeting that lays out the items up for a vote—like who will sit on the board, executive pay, and major corporate decisions—and provides background so shareholders can decide how to cast their votes or appoint someone to vote for them. Think of it as an agenda plus a ballot and briefing notes, important because the outcomes can change control, strategy, and value.
"Stockholders of record as of the close of business on August 4, 2026"
Stockholders of record are the people or entities whose names appear on a company's official shareholder list on a specific cutoff date set by the company or its transfer agent; only those listed are entitled to receive dividends, vote at shareholder meetings, or participate in other corporate actions. Think of it like a guest list for an event: being on the list on the set day determines who gets the benefits and rights, so investors must own shares before the cutoff to qualify.
DURHAM, N.C., July 24, 2026 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS) (the “Company” or “Pelthos”) today announced that it will hold its 2026 Annual Meeting of Stockholders virtually on Tuesday, September 29, 2026 at 9:00 a.m. Eastern Time.Stockholders of record as of the close of business on August 4, 2026 are entitled to notice of and to vote at the 2026 Annual Meeting. The Company anticipates filing the Notice of Annual Meeting and proxy statement in early August 2026.
The date of the 2026 Annual Meeting represents a change of more than 30 days from the anniversary of the Company’s 2025 Annual Meeting.Given the adjustment, stockholder proposals pursuant to Rule 14a-8 of the Securities Exchange Act of 1934, as amended, must be received in writing by the Company before the close of business on August 3, 2026 to be considered for inclusion in the Company’s proxy materials for the 2026 Annual Meeting.
About Pelthos Therapeutics Pelthos Therapeutics is a commercial-stage biopharmaceutical company focused on building and advancing a portfolio of differentiated cutaneous infectious disease products that address unmet patient needs. ZELSUVMI® (berdazimer) topical gel, 10.3%, the company’s lead product, is the first and only prescription therapy approved for use at home by patients, parents, and caregivers to treat molluscum contagiosum. The company’s portfolio of assets includes XEPI® (ozenoxacin) Cream, 1%, a topical treatment for impetigo, and XEGLYZE® (abametapir), a topical treatment for head lice. More information is available at https://pelthos.com/. Follow Pelthos on LinkedIn and X.
When is the Pelthos Therapeutics (PTHS) 2026 annual meeting of stockholders?
The Pelthos Therapeutics 2026 annual meeting will be held virtually on September 29, 2026 at 9:00 a.m. Eastern Time. According to Pelthos Therapeutics, this meeting date is more than 30 days from the anniversary of the 2025 annual meeting.
Who is eligible to vote at the Pelthos Therapeutics (PTHS) 2026 annual meeting?
Stockholders of record at the close of business on August 4, 2026 are eligible to vote. According to Pelthos Therapeutics, only these stockholders are entitled to notice of and to vote at the 2026 Annual Meeting.
How will the Pelthos Therapeutics (PTHS) 2026 annual meeting be conducted?
The Pelthos Therapeutics 2026 annual meeting will be held virtually. According to Pelthos Therapeutics, the online meeting is scheduled for September 29, 2026 at 9:00 a.m. Eastern Time, with additional access details expected in the proxy materials.
What is the deadline for Pelthos Therapeutics (PTHS) stockholder proposals for the 2026 annual meeting?
Stockholder proposals under Rule 14a-8 must be received by August 3, 2026. According to Pelthos Therapeutics, timely proposals may be considered for inclusion in the company’s proxy materials for the 2026 Annual Meeting.
When will Pelthos Therapeutics (PTHS) file its 2026 annual meeting proxy statement?
Pelthos Therapeutics anticipates filing its Notice of Annual Meeting and proxy statement in early August 2026. According to Pelthos Therapeutics, this filing will provide detailed information on the 2026 Annual Meeting and related voting matters.
